Find information on thousands of medical conditions and prescription drugs.

Betadine

Betadine is the name of a consumer-available antiseptic used to treat minor cuts on humans and animals. Povidone-iodine is also used to prepare the skin prior to surgery, as it is a strong broad-spectrum topical microbicide. It is a povidone-iodine solution, used as a broad spectrum topical microbicide. Most over-the-counter solutions are 10% povidone-iodine. Povidone-iodine leaves a yellow film on the skin, which is a barrier for bacteria. The film is non-irritating.

Home
Diseases
Medicines
A
B
Baciim
Bacitracin
Baclofen
Bactrim
Bactroban
Barbexaclone
Barbital
Baros
Basiliximab
Baycol
Beclamide
Beclometasone
Beclovent
Beconase
Beldin
Benadryl
Benazepril
Bendroflumethiazide
Benserazide
Bentiromide
Benylin
Benzaclin
Benzalkonium chloride
Benzocaine
Benzonatate
Betacarotene
Betadine
Betahistine
Betamethasone
Betaxolol
Bextra
Biaxin
Bibrocathol
Bicalutamide
Bicillin
Biclotymol
Biotin
Bisoprolol
Bleomycin
Blocadren
Boldenone
Boniva
Bontril
Bosentan
Bravelle
Brethaire
Brevibloc
Brevicon
Bricanyl
Bromazepam
Bromelain
Bromhexine
Bromocriptine
Brompheniramine
Bronkodyl
Bronopol
BSS
Bucet
Budesonide
Bumetanide
Bupivacaine
Buprenex
Buprenorphine
Buserelin
Buspar
Buspirone
Busulfan
Butalbital
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Read more at Wikipedia.org


[List your site here Free!]


Cosmetic bilateral leg lengthening: EXPERIENCE OF 54 CASES
From Journal of Bone and Joint Surgery, 10/1/05 by Catagni, M A

The Ilizarov method for leg lengthening was used for cosmetic reasons in 54 patients with constitutional short stature. A mean lengthening of 7 cm with a low rate of complications produced an excellent or good outcome in all the patients, including improvement in psychological disturbances related to short stature. Those who undergo the procedure must be highly motivated, fully informed and understand the technique and possible complications. We suggest that the Ilizarov method for cosmetic limb lengthening is a technique without major complications. However, it requires careful follow-up, and the involvement of orthopaedic surgeons who are familiar with use of the circular frame and are experienced in limb lengthening and correction of deformity for pathological conditions.

Society places considerable value on physical beauty and presentation. These prejudices extend to short stature1 which may cause psychological disturbance, mostly in early adolescence,- but also in childhood.3 Leg lengthening by the Ilizarov method is well established for the treatment of patients with dwarfism4 and deformities resulting from congenital anomalies, trauma, tumour or infection.4,5

Recently, the technique has been applied to individuals with constitutional short stature6 who wish to be taller. This new application is called cosmetic leg lengthening or symmetrical extended limb lengthening and has been compared with the more simple options of plastic surgery.7 It is becoming more popular and is generating interest and controversy.7 However, there are few, if any, reports on the use of the Ilizarov method to gain height for aesthetic purposes and little is known of the inherent risks and benefits.

Patients and Methods

Between 1985 and 2001, of a total of 136 individuals seeking cosmetic leg lengthening, 54 (32 men and 22 women) with constitutional short stature were selected for bilateral leg lengthening using a hybrid advanced fixator.4,8,9

Their mean age was 25.8 years (17 to 47); 28.1 in men and 23.6 in women. Their mean pre-operative height was 153 cm (141 to 174); 159 cm in men (145 to 174) and 147 cm in women (141 to 155). Two patients had a varus deformity of the knee which also required correction during the treatment. All patients were practising non-competitive sports.

Pre-operative assessment and selection of cases. Assessment included psychological evaluation of the patients and their families, anthropometry with particular attention to the proportions of the limbs and trunk and radiological examination for deformity and/or leg-length discrepancy.

During the first consultation the authors examined the impact of short stature on the patient's everyday life and how they might cope with difficulties encountered during treatment. Actual and perceived problems related to short stature were also discussed. We considered a good motivation for gaining height the functional limitations of short stature, including the difficulty to drive motorcycles of larger sizes. All the patients wishing to undergo this surgery were invited to discuss treatment with at least two other patients, one undergoing treatment and one after recovery.

Those selected for lengthening were below the 5th percentile for age and gender, and had no illness, hormonal deficiency or dysmorphic syndrome.2 In order to exclude dysmorphophobia,10 a detailed history of all previous aesthetic interventions was included.

Patients with deformity and discrepancy were treated by simultaneous correction and lengthening.

Operative technique. The hybrid advanced fixator (Amplimedical, SpA, Milan, Italy) is a modification of the classic Ilizarov fixator11 combining Kirschner wires with half-pins and full rings with arches.4,8,9 The standard apparatus (three rings and one half-ring for the leg) was assembled pre-operatively with the rings being sized directly on to the patient's legs and the wires and half-pins applied with routine transfixation. The whole construct was connected with threaded rods.8,9 Two osteotomies with a Gigli saw or multiple drill holes were carried out, one below the tibial tuberosity and the other at the supramalleolar level. A fibular osteotomy was performed at the junction of the middle and distal thirds.

A hand-controlled drill with a speed of 0 to 950 revolutions per minute was used for the insertion of the wires and pilot holes were drilled before insertion of the half-pins.

Post-operative care and follow-up. Lengthening was started on the tenth post-operative day at a rate of 0.75 mm per day (1/4 turn every eight hours) for each tibial osteotomy. Weight-bearing was encouraged on the second post-operative day as tolerated, following a rehabilitation programme of gradual increased load bearing and physiotherapy. Pin care began on the first post-operative day with the use of hydrogen peroxide and betadine, and attention to sterile technique. The patient was discharged with instructions on bi-weekly care of the pin site. Clinical and radiological examinations were carried out every 30 to 40 days in order to assess the formation of new bone, pin sites, patient satisfaction, tibial length and joint movements.

We considered a bilateral leg lengthening of 5 to 8 cm to be satisfactory. The radiological criteria for successful lengthening was complete bone bridging in at least two projections. Bone regeneration was assessed clinically by loosening the connecting rods and applying stress.

If consolidated new bone was confirmed clinically and radiologically, the frames were removed in the clinic, usually without anaesthesia. Fibreglass casts or braces which included the foot were applied for a mean of six weeks.

The patients were reviewed every three months for the first year and then every two years. This included evaluation of patient satisfaction, possible axial deviation, the range movement of the knee and ankle, pronation of the foot, leg-length discrepancy and scars. Based on these parameters and scores given by the patient and physician, the outcome was classified as poor (0 to 4), fair (5 to 9), good (10 to 14) or excellent (15 to 18).

The psychological outcome after treatment was evaluated by determining improvement in self esteem, distress and shyness and quality of life. All the patients were asked if they would undergo the procedure again and whether they would recommend it to others of similar stature.

Results

In the 54 patients undergoing simultaneous leg lengthening, the mean lengthening achieved was 7 cm (5 to 11; Fig. 1) over a mean of nine months and 15 days of treatment in the frame (7 to 18). Treatment in the frame was followed by the wearing of fibreglass casts in 26 patients (48.15%) and of commercial braces including the foot in 28 (51.85%). All had physiotherapy for a mean of six weeks (4 to 8). The mean follow-up was 6.25 years (1 to 16). No patient was lost to follow-up.

An associated varus deformity of the knee was corrected in two patients. In 19 patients (35.2%), bilateral lengthening of the tendo Achillis was necessary for an equinus deformity which developed during distraction. One patient refused this operation.

Complications. Autologous cancellous bone grafting from the iliac crest was undertaken for atrophy of the new bone at the distal distraction site in two patients. In one patient a repeat fibular osteotomy was performed for early consolidation. In three patients (four limbs), collapse of the regenerate occurred after removal of the frame with proximal varus in one and proximal anterior bowing and distal valgus in the other two. This was corrected by the application of a new Ilizarov frame.

Other complications included proximal anterior tibial bowing (4° and 5°, respectively) resulting in a minor loss of knee extension (two), slight recurvatum of the proximal tibia of 3° which did not affect the movement of the knee (one), distal varus of 4° (two), distal valgus (between 3° and 5°) resulting in pronation and minor stiffness of the subtalar joint (five), limitation of dorsiflexion of the ankle to 20° (two) and a leg-length discrepancy of 10 mm (one). In 26 patients (48.2%) there was superficial infection at the pin site. No patient required hospital admission because of a pin site infection.

Most responded to local pin-site care and oral antibiotics. In some cases, wires or pins had to be removed without compromising the stability of the frame. Although a further surgical procedure was required in 25 patients (46.3%); this did not significantly lengthen the time in the frame or result in further complications.

In all cases, neither the public-health system nor the patients' medical insurance covered the cost of treatment, since constitutional short stature is not considered to be pathological. The mean cost of the operation, including hospital fees was euro12 000, plus an additional euro3000 for bilateral tendo Achillis lengthening.

During treatment 30 patients (15 students and 15 office workers) continued to attend school or work full time, four (three physicians and one engineer) delegated some of their work, 19 (manual and factory workers) took sick or unpaid leave for ten to 12 months; and one was unemployed. All patients resumed fully their previous sporting activities, with the exception of the patient who refused lengthening of tendo Achillis.

At the latest follow-up, all the patients were satisfied with the improvement in self-esteem, distress or shyness and quality of life. They all stated that they would recommend the treatment to others of similar stature. When asked if they would have the procedure again, 48 said that they would and the remaining six were undecided.

Based on the parameters of patient satisfaction, axial deviation, restricted joint movement, pronation of the foot, leg-length discrepancy and scars, the clinical results were excellent in 49 patients (90.7%) and good in five (9.3%). The final aesthetic effects were satisfactory in all cases (Fig. 2).

Discussion

Limb lengthening with the Ilizarov apparatus has been used for pathological conditions such as dwarfism, hemimelia and other congenital or acquired limb-length discrepancy4,5,10,11 in our unit for the past 24 years and in recent years we have broadened the scope to include cosmetic and psychological indications based upon patient demand.

We selected only patients with constitutional short stature which is defined as a height which is below the fifth percentile for age and gender and caused by illness, hormonal deficiency or dysmorphism.3 Although not considered an illness, the condition can cause psychological1-3,12 and functional disadvantages.13

Selection of patients for cosmetic leg lengthening requires careful psychological investigation. Those who undergo this procedure must be highly motivated, fully informed and understand the procedure and possible complications. Moreover, they should be aware that the cost of treatment is not covered by medical insurance or the public-health system.

Dysmorphophobia or body dysmorphic disorder is a distressing and impairing preoccupation with an imagined or grossly exaggerated defect of appearance. This disorder is associated with high rates of occupational and social disability, hospitalisation and suicide attempts.8 Patients with dysmorphophobia may seek cosmetic operations to alter their subjective perceived abnormality. We excluded such patients but other authors have accepted them for limb lengthening.14

Our results were gratifying in that the patients considered their stature as normal and they could shed their inferiority complex. We conclude that the Ilizarov method for cosmetic limb lengthening is a technique without major complications. However, it requires careful follow-up and the involvement of orthopaedic surgeons who are familiar with the circular frame and experienced in limb lengthening and correction of deformity for pathological conditions. Patients eligible for the procedure should be carefully selected and their co-operation is paramount for success.

Supplementary Material

A further opinion by Mr Christopher Bradish is available with the electronic version of this article on our website at www.jbjs.org.uk

No benefits in any form have been received or will be received from a commercial party related directly or indirectly to the subject of this article.

References

1. Molinari E, Sartorio A. Psiche e ebassa stature: aspetti biologica e psico-sociali cello sviluppo umano. Milano: Raffaello Cortina Editore, 1998 (in Italian).

2. Stathis SL, O'Callaghan MJ, Williams GM, et al. Behavioural and cognitive associations of short stature at 5 years. J Paediatr Child Health 1999;35:562-7.

3. Kranzler JH, Rosenbloom AL, Proctor B, Diamond FB Jr, Watson M. Is short stature a handicap?: a comparison of the psychosocial functioning of referred and nonreferred children with normal short stature and children with normal stature. J Pediatr 2000;136:96-102.

4. Cattaneo R, Villa A, Catagni MA, Tentori L. Limb lengthening in achondroplasia by Ilizarov's method. Int Orthop 1988;12:173-9.

5. Ottaviani G, Randelli P, Catagni MA. Segmental cement extraction system (SEGCES) and the Ilizarov method in limb salvage procedure after total knee cemented prosthesis removal in a former osteosarcoma patient. Knee Surg Sports Traumatol Arthrose 2005:in press.

6. Cattaneo R, Catagni MA, Lovisetti L. Les allongements bilatéraus simultanés des jambes pour des raisons esthétiques. Rev Chir Orthop Reparatrice Appar Mot 2003; 89(Suppl):57.

7. Watts J. China's cosmetic surgery craze: leg-lengthening operations to fight height prejudice can leave patients crippled. Lancet 2004;363:958.

8. Catagni MA, Bolano L, Cattaneo R. Management of fibular hemimelia using the Ilizarov method. Orthop Clin North Am 1991;22:715-22.

9. Catagni MA. Treatment of fractures, nonunions and bone loss of the tibia with the Ilizarov method. Milan: II Quadratino, 1998.

10. Phillips KA. Body dysmorphic disorder and depression: theoretical considerations and treatment strategies. Psychiatr Q 1999;70:313-31.

11. Ilizarov GA. The tension-stress effect on the genesis and growth of tissues. Part I: the influence of stability of fixation and soft-tissue preservation. Clin Orthop 1989; 238:249-81.

12. Stratford R, Mulligan J, Downie B, Voss L. Threats to validity in the longitudinal study of psychological effects: the case of short stature. Child Care Health Dev 1999; 25:401-9.

13. Scott PA, Candler PD, Li JC. Stature and seat position as factors affecting fractionated response time in motor vehicle drivers. Appl Ergon 1996;27:411-16.

14. Aldegheri R, Dall'Oca C. Limb lengthening in short stature patients. J Pediatr Orthop B 2001;10:238-47.

M. A. Catagni, L. Lovisetti, F. Guerreschi, A. Combi, G. Ottaviani

From The "Alessandro Manzoni" Hospital, Lecco and "S. Camilla" Hospital, Milan, Italy

* M. A. Catagni, MD, Orthopaedic Surgeon, Chairman

* L. Lovisetti, MD, Staff Orthopaedic Surgeon

* F. Guerreschi, MD, Staff Orthopaedic Surgeon

* A. Combi, MD, Resident Orthopaedic Surgeon

Department of Orthopaedics and Ilizarov Unit

"Alessandro Manzoni" Hospital, Via dell'Eremo 9/11, 23900 Lecco, Italy.

* G. Ottaviani, MD, PhD, Assistant Professor of Pathology

Institute of Pathology University of Milan, Via della Commenda 19, 20122 Milan, Italy.

Correspondence should be sent to Dr M. A. Catagni; e-mail: maurizio@catagni.it

©2005 British Editorial Society of Bone and Joint Surgery

doi:10.1302/0301-620X.87B10. 16468 $2.00

J Bone Joint Surg [Br] 2005;87-B:1402-5.

Received 4 March 2005; Accepted after revision 24 May 2005

Copyright British Editorial Society of Bone & Joint Surgery Oct 2005
Provided by ProQuest Information and Learning Company. All rights Reserved

Return to Betadine
Home Contact Resources Exchange Links ebay